(57) A total of 71 patients (21 with ovarian cancer, 24 with endometrial cancer, and 26 with cervical cancer) were included in the study, and patients with recurrent or persistent ovarian, endometrial, and cervical cancer were divided into PIK3CA-wt and PIK3CA-m groups. This evidence concerns the gene PIK3CA and ovarian cancer.